CNP-GlcNAc

NameCNP-GlcNAc
Synonyms2-Chloro-4-nitrophenyl β-D-N-acetylglucosaminide
CAS Number103614-82-0
Molecular FormulaC14H17ClN2O8
Molecular Weight376.75 g/mol
Specifications & Purity98% (Vacuum foil packaging)

  Share
Guaranteed Safe CheckoutTrust

CNP-GlcNAc (2-Chloro-4-nitrophenyl β-D-N-acetylglucosaminide, CAS 103614-82-0) is a chromogenic substrate specifically designed for quantitative spectrophotometric detection of β-N-acetylglucosaminidase (NAGase, EC 3.2.1.52; also known as β-hexosaminidase) activity through enzymatic hydrolysis of the β-glycosidic bond, releasing 2-chloro-4-nitrophenolate anion with strong yellow absorbance at 405 nm (ε ≈ 14,300 M⁻¹cm⁻¹) for sensitive kinetic assays down to 0.001 U/L enzyme concentrations. With molecular formula C14H17ClN2O8 (MW 376.75 g/mol), this white to off-white crystalline solid features β-D-N-acetylglucosamine (GlcNAc) O-linked via C1 to the electron-deficient 2-chloro-4-nitrophenyl aglycone, where ortho-chloro substitution enhances leaving group efficiency (pKa ~7.1) and hydrolysis kinetics (kcat/Km ~10^4 M⁻¹s⁻¹ for human HexA/HexB isoforms) while maintaining strict β-anomeric specificity over α-GlcNAc linkages. Routinely employed in clinical diagnostics for lysosomal storage disorders (Tay-Sachs/Sandhoff disease via HexA deficiency), urinary NAGase screening for renal tubular damage (diabetes/nephrotoxicity), and glycobiology research profiling GH3/GH20 family enzymes in chitin degradation/microbiome studies, it supports 96-well formats (0.2-1 mM substrate, pH 4.3-4.8, 37°C) with excellent linearity (0.001-2 U/L) and minimal interference from endogenous chromophores. Superior to p-nitrophenyl-β-GlcNAc by 15-25% faster turnover due to chlorine enhancement, the yellow product’s pH stability (6-10) enables reliable endpoint reads, positioning CNP-GlcNAc as the preferred reagent for therapeutic monitoring, enzyme replacement therapy evaluation, and high-throughput screening of chitinase/NAGase inhibitors targeting fungal infections, cancer metastasis, and inflammatory joint diseases.

Appearance

  • White to off-white crystalline powder.
  • Hydrolysis yields bright yellow solution (λmax 405 nm).

Source

  • Koenigs-Knorr synthesis: protected β-D-GlcNAc donor + 2-chloro-4-nitrophenol.
  • Commercial analytical grade (Hepattack/GeneSeqTools >98%).

Molecular Weight and Structure

  • Formula: C14H17ClN2O8; MW 376.75 g/mol.
  • (2R,3R,4R,5S,6R)-2-(2-acetamido-2-(2-chloro-4-nitrophenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol.

Sugar Specificity

  • Selective β-D-N-acetylglucosaminide for β-N-acetylhexosaminidases (HexA/B).
  • 500x preference over α-GlcNAc linkages.

Biological Activity

  • Chromogenic NAGase substrate; 1 U = 1 μmol CNP/min, pH 4.5, 37°C.
  • Km 0.2-0.8 mM (human HexA).

Purity and Microbial Contamination

  • ≥98% (HPLC); research/diagnostic grade.
  • Synthetic; non-sterile.

Identity and Quality Control

  • ¹H-NMR (β-anomeric H 4.9 ppm d, J=8.0 Hz); HRMS m/z 377 [M+H]+.
  • Quantitative hydrolysis yield at A₄₀₅.

Shelf Life and Storage

  • 3 years -20°C desiccated; aqueous 10 mM stable 3 months -80°C.
  • Moisture/light protected.

Applications

  • Lysosomal storage disorder diagnostics (Tay-Sachs); renal NAGase screening.
  • Chitinase assays, HTS inhibitors.

Key Characteristics

  • 15-25% faster than pNP-β-GlcNAc; high sensitivity.
  • pH-stable yellow chromophore.

Citation Links

2. MSDS

3. Tech Data Sheets/Manuals

Based on 0 reviews

0.00 Overall
0%
0%
0%
0%
0%
Be the first to review “CNP-GlcNAc”

Your email address will not be published. Required fields are marked *

Write a review

Reviews

There are no reviews yet.

SKU: A22-1020 Category: 
My Cart
Close Wishlist
Close Recently Viewed
Categories